Glycated hemoglobin A1c (HbA1c) and diabetes: A new era?

Abstract

In January 2011 the American Diabetes Association (ADA) published the latest guidelines for the diagnosis and treatment of diabetes mellitus (DM) 1,2. Despite some controversies, glycated hemoglobin A1c (HbA1c), an established marker of long-term glycemia traditionally used to assess the quality of DM management, remained an independent criterion for the diagnosis of DM, and indeed now appears to be well established in the USA. This has far-reaching implications for clinical practice worldwide. © 2011 Informa UK Ltd All rights reserved.